A Study to Evaluate the Effects of a Dietary Supplement on Children's Health and Development Outcomes.
NCT ID: NCT06704178
Last Updated: 2025-07-24
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2024-06-12
2025-02-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Trial to Study the Impact of a Nutritional Beverage on Tests of Memory in Healthy Preschool Age Children
NCT02177942
Nutrition, Physical Performance & Fitness in Indian School Children
NCT00876018
Efficacy of a Multiple Micronutrient-Fortified Lipid-Based Nutrient Supplement for Children Under Two in Cambodia
NCT02257762
Micronutrient Supplementation in Children With ASD
NCT05268744
Randomized Controlled Trial in South Africa Comparing the Efficacy of Complementary Food Products on Child Growth
NCT01845610
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Arm
Participants in this arm will take NuBest Tall Growth Protein Powder daily for 6 months.
NuBest Tall Growth Protein Powder
NuBest Tall Growth Protein Powder includes a proprietary blend of vitamins, minerals, and probiotics designed to enhance children's health outcomes.
Placebo Arm
Participants in this arm will take a placebo product daily for 6 months.
Placebo Powder
The placebo powder is designed to mimic the appearance and taste of the NuBest Tall Growth Protein Powder but does not contain the active ingredients.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NuBest Tall Growth Protein Powder
NuBest Tall Growth Protein Powder includes a proprietary blend of vitamins, minerals, and probiotics designed to enhance children's health outcomes.
Placebo Powder
The placebo powder is designed to mimic the appearance and taste of the NuBest Tall Growth Protein Powder but does not contain the active ingredients.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing to refrain from giving their child any vitamins, minerals, or herbal supplements of any kind for the duration of the study.
* Parents willing to weigh and measure the height of their child throughout the study.
* Generally healthy - do not have any uncontrolled chronic disease.
Exclusion Criteria
* Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
* Is undergoing or planning to undergo significant medical procedures in the next six months.
* A history of severe allergic reactions, including but not limited to any of the product's ingredients.
* Any child with a dairy allergy or lactose intolerance.
* Has undergone any surgeries or invasive treatments in the last six months.
* Has had any major illness in the last three months.
* Having any planned invasive medical procedures during the study period.
* Currently participating in any other clinical study.
* Unwilling to follow the study protocol.
* Any child diagnosed with attention-deficit disorder (ADD) or attention-deficit hyperactivity disorder (ADHD).
* Any child currently taking or have taken in the last 3 months any prescription medication targeting ADD or ADHD (such as Adderall, Concerta, Focalin, Evekeo, or Ritalin).
* Any child that is a 'fussy' eater or who the parent suspects may not tolerate consuming the test product daily for six months.
10 Years
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Citruslabs
INDUSTRY
NuBest
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Citruslabs
Santa Monica, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20424
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.